Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 8 min 48 sec ago

BONESUPPORT(TM) Reports Expansion Of Company's CERAMENT(TM) Drug Eluting Procedure Registry

Tue, 02/02/2016 - 15:20
CERAMENT™/G registry now includes 230 cases conducted in 18 hospitals across 9 countries Registry now updated to include CERAMENT™ V procedures LUND, Sweden, Feb. 2, 2016 -- (Healthcare Sales & Marketing Network) -- BONESUPPORT™, an emerging leader ...
Devices, Orthopaedic
BONESUPPORT, CERAMENT, bone graft

PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for APLIDIN(R) (plitidepsin) Covering Several Asian Countries

Tue, 02/02/2016 - 15:14
MADRID, February 2, 2016 -- (Healthcare Sales & Marketing Network) -- PharmaMar (PHM.V) today announced an agreement with Singapore-based Specialised Therapeutics Asia Pte, Ltd (STA) to market marine-based anti-tumour compound APLIDIN® (plitidepsin) f...
Biopharmaceuticals, Oncology, Licensing, Distribution
PharmaMar, Specialised Therapeutics Asia, APLIDIN, plitidepsin

Collegium Provides Litigation Update

Tue, 02/02/2016 - 15:09
CANTON, Mass., Feb. 02, 2016 -- (Healthcare Sales & Marketing Network) -- Collegium Pharmaceutical, Inc. (COLL) today provided an update regarding its ongoing litigation with Purdue Pharma L.P. (“Purdue”). On February 1, 2016, the U.S. Court of Appeals for...
Biopharmaceuticals, Litigation
Collegium Pharmaceutical, Purdue Pharma, OxyContin OP, Xtampza

Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in Children and Adolescents with Tourette Syndrome

Tue, 02/02/2016 - 13:33
Six-Week T-Force GREEN Study to Assess the Safety, Tolerability and Efficacy of Valbenazine in 90 Pediatric Subjects SAN DIEGO, Feb. 2, 2016 -- (Healthcare Sales & Marketing Network) -- Neurocrine Biosciences, Inc. (NBIX) announced today that it has in...
Biopharmaceuticals, Neurology
Neurocrine Biosciences, valbenazine, Tourette syndrome, T-Force GREEN

Hansen Medical(R) Announces FDA Clearance of the Magellan(TM) Robotic Catheter eKit

Tue, 02/02/2016 - 13:14
MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the Magellan™ Robotic C...
Devices, Interventional, FDA
Hansen Medical, intravascular robotics, Magellan, Robotic Catheter

Impax Receives Tentative FDA Approval for Generic Version of Vytorin(R) (ezetimibe and simvastatin) Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg

Tue, 02/02/2016 - 13:08
HAYWARD, Calif., Feb. 2, 2016 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (IPXL) today announced that Impax has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application...
Biopharmaceuticals, Generics, Cardiology, FDA
Impax Laboratories, ezetimibe, simvastatin, Vytorin

Versartis Reports Confirmatory Top-Line Two-Year Data from Ongoing Extension Study of Somavaratan in GHD Children

Tue, 02/02/2016 - 13:01
Safe and well tolerated over two years Height velocity (HV) in second year comparable to published US rhGH daily dosing data; further confirms Phase 3 dose and schedule Extremely high rate of adherence to dosing schedule in Extension Study (18 months...
Biopharmaceuticals, Endocrinology
Versartis, somavaratan, rhGH, growth hormone deficiency

MISSION Therapeutics Raises £60 million to Progress Development of Novel DUB Inhibitors from Innovative Drug Platform

Tue, 02/02/2016 - 12:53
Woodford Patient Capital Trust joins existing syndicate supporting transition to clinical development CAMBRIDGE, England, February 2, 2016 -- (Healthcare Sales & Marketing Network) -- MISSION Therapeutics, a drug discovery and development company focus...
Biopharmaceuticals, Oncology, Neurology, Venture Capital
MISSION Therapeutics, deubiquitylating enzyme, ubiquitin

Bioness Announces the Publication of StimRouter(TM) Neuromodulation System Clinical Trial

Mon, 02/01/2016 - 19:26
VALENCIA, Calif., Feb. 1, 2016 -- (Healthcare Sales & Marketing Network) -- Bioness Inc. announced today the successful results from the company's 1-year clinical trial of the StimRouter™ Neuromodulation System. The results have been published in the Jan...
Devices, Neurology
Bioness, StimRouter, Neuromodulation

BioPharmX Appoints Marie-Louise Bots as Senior VP of Corporate Development

Mon, 02/01/2016 - 15:39
Business executive brings 30+ years of multinational partnership building experience to guide international licensing and strategic development MENLO PARK, Calif., Feb. 1, 2016 -- (Healthcare Sales & Marketing Network) -- Veteran corporate dealmaker Ma...
Biopharmaceuticals, Dermatology, Personnel
BioPharmX

Mallinckrodt Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company

Mon, 02/01/2016 - 15:34
CHESTERFIELD, United Kingdom, Feb. 1, 2016 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (MNK), a leading specialty biopharmaceutical company, today announced it closed the acquisition of the global portfolio of three commercial-stage topi...
Devices, Surgery, Acquisitions
Mallinckrodt, The Medicines Company, RECOTHROM, PreveLeak, RAPLIXA

Seno Medical Instruments Appoints Tom Umbel as Chief Executive Officer

Mon, 02/01/2016 - 15:29
SAN ANTONIO, Feb. 1, 2016 -- (Healthcare Sales & Marketing Network) -- Seno Medical Instruments, Inc., the leader in improving the process of diagnosing breast cancer through the development of an opto-acoustic (OA) device, today announced the appointment...
Devices, Diagnostics, Oncology, Personnel
Seno Medical Instruments, opto-acoustic imaging, breast cancer

Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer

Mon, 02/01/2016 - 15:27
FOSTER CITY, Calif., Feb. 1, 2016 -- (Healthcare Sales & Marketing Network) -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distri...
Biopharmaceuticals, Personnel
Aoxing Pharmaceutical

Merial Appoints Susan Sholtis as President, North America

Mon, 02/01/2016 - 15:24
DULUTH, Ga., Feb. 1, 2016 -- (Healthcare Sales & Marketing Network) -- Merial, the animal health division of Sanofi, today announced the appointment of Susan Sholtis as President of its North American operations. Sholtis rejoins the company after a serie...
Biopharmaceuticals, Veterinary, Personnel
Merial, Sanofi

Stryker Announces Definitive Agreement to Acquire Sage Products, LLC from Madison Dearborn Partners for $2.775 Billion

Mon, 02/01/2016 - 15:21
Kalamazoo, Michigan - February 1, 2016 -- (Healthcare Sales & Marketing Network) -- Stryker Corporation (NYSE: SYK) announced today a definitive agreement to acquire Sage Products, LLC ("Sage") from Madison Dearborn Partners in an all cash transa...
Devices, Orthopaedic, Neurosurgery, Mergers & Acquisitions
Stryker, Sage Products

Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence

Mon, 02/01/2016 - 15:13
ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT, BROADENS DIAGNOSTICS FOOTPRINT AND ENHANCES ACCESS TO FAST-GROWING DIAGNOSTICS CHANNELS Transaction expected to be immediately accretive to Abbott's ongoing earnings per share upon close...
Devices, Diagnostics, Mergers & Acquisitions
Abbott, Alere

Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis

Mon, 02/01/2016 - 13:39
CAMBRIDGE, MA--(Healthcare Sales & Marketing Network) - Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan and protein processing diseases, today announced...
Biopharmaceuticals, FDA
Proteostasis, DRT platform, Cystic Fibrosis

New Company ProtoStar(TM) Launched to Produce Safer, Next-Generation Assistive Mobility Products Designed to Reduce Fall Risk and Enable Users to Stand Upright and Walk Longer

Mon, 02/01/2016 - 13:33
Initial product launch scheduled for February 2016 Company names board of directors comprised of prominent industry members SAN DIEGO, Feb. 1, 2016 -- (Healthcare Sales & Marketing Network) -- ProtoStar™, Inc., today announced its debut as a new San...
Devices
ProtoStar, LifeWalker, assistive mobility

Trovagene Enters into Agreement with FedMed, Inc. and Significantly Expands Patient Access to Its Precision Cancer Monitoring Platform

Mon, 02/01/2016 - 13:10
FedMed brings in-network health plan access to an additional 40 million covered lives SAN DIEGO, Feb. 1, 2016 -- (Healthcare Sales & Marketing Network) -- Trovagene, Inc. (TROV), a developer of cell-free molecular diagnostics, announced today that it h...
Diagnostics, Oncology
Trovagene, Precision Cancer Monitoring

Dr. Reddy’s Laboratories Receives USFDA Tentative Approval for Zenavod(TM) (doxycycline) Capsules, 40 mg for the Treatment of Rosacea in Adults

Mon, 02/01/2016 - 13:04
HYDERABAD, India & PRINCETON, N.J.--(Healthcare Sales & Marketing Network)--Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announced today the U.S. Food and Drug Administration (US FDA) tentative approval for Zenavod™ (doxycycline) Capsul...
Biopharmaceuticals, Dermatology, FDA
Dr. Reddy's Laboratories, Zenavod, doxycycline, rosacea

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong